Form 4 holding
EVP, Bioscience & Medtech
Avantor, Inc.
- Security class
- Common Stock
- Shares / value
- 362,859
- Estimated value
- $3,225,816
- Report date
- 23 Feb 2026
- Price
- $8.89
- Ownership
- Direct
Benoit Gourdier
Insider Reports History
- Reporting-owner location
- Radnor, PA
- Latest reporting-owner signature
-
/s/ Scott Baker, by power of attorney for Benoit Gourdier
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Benoit Gourdier
Form 4 holding
EVP, Bioscience & Medtech
Avantor, Inc.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 528,848
- Estimated value
- Report date
- 19 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Benoit Gourdier
4
AVTR
Avantor, Inc.
- Report period
- 23 Feb 2026
- Transactions
- 1
- Transaction value
- -$26,928
- Accepted by SEC
- 25 Feb 2026, 17:27
- Role
- EVP, Bioscience & Medtech
- Next action
- Open filing details
4
AVTR
Avantor, Inc.
- Report period
- 19 Feb 2026
- Transactions
- 3
- Transaction value
- -$37,565
- Accepted by SEC
- 23 Feb 2026, 20:53
- Role
- EVP, Bioscience & Medtech
- Next action
- Open filing details
4
AVTR
Avantor, Inc.
- Report period
- 02 Oct 2025
- Transactions
- 1
- Transaction value
- -$17,405
- Accepted by SEC
- 03 Oct 2025, 16:28
- Role
- EVP, Bioscience Production
- Next action
- Open filing details
4
AVTR
Avantor, Inc.
- Report period
- 09 May 2025
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 12 May 2025, 17:32
- Role
- EVP, Bioscience Production
- Next action
- Open filing details
4
AVTR
Avantor, Inc.
- Report period
- 20 Feb 2025
- Transactions
- 3
- Transaction value
- -$49,167
- Accepted by SEC
- 24 Feb 2025, 17:31
- Role
- EVP, Bioscience Production
- Next action
- Open filing details
4
AVTR
Avantor, Inc.
- Report period
- 02 Oct 2024
- Transactions
- 1
- Transaction value
- -$32,257
- Accepted by SEC
- 04 Oct 2024, 17:00
- Role
- EVP, Bioscience Production
- Next action
- Open filing details
4
AVTR
Avantor, Inc.
- Report period
- 23 Feb 2024
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 27 Feb 2024, 17:02
- Role
- EVP, Biopharma Production
- Next action
- Open filing details
4
AVTR
Avantor, Inc.
- Report period
- 02 Oct 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 04 Oct 2023, 16:40
- Role
- EVP, Biopharma Production
- Next action
- Open filing details
3
AVTR
Avantor, Inc.
- Report period
- 02 Oct 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 04 Oct 2023, 16:37
- Role
- EVP, Biopharma Production
- Next action
- Open filing details